Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib

Clinical trial NCT05265988 · COMPLETED

Trial details

NCT number: NCT05265988
Sponsor: Alfredo Berruti
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Prostate

Start date: 2021-11-29
Primary completion: 2024-06-29
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.